Prostate Cancers in Men with Low PSA Levels — Must We Find Them?

by Carter, H. Ballentine
Published 2004

Active Surveillance for Prostate Cancer: An Underutilized Opportunity for Reducing Harm

by Carter, H. Ballentine
Published 2012

Management of low (favourable)-risk prostate cancer

by Carter, H. Ballentine
Published 2011

Should prostate-specific antigen velocity be abandoned?

by Loeb, Stacy, Carter, H Ballentine
Published 2011

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report

by Johnson, Michael H., Carter, H. Ballentine
Published in Urol Case Rep (2015)

The Mind

by Reis, Leonardo de Oliveira, Carter, H. Ballentine
Published in Int Braz J Urol (2015)

The Importance of Pelvic Lymph Node Dissection in Men With Clinically Localized Prostate Cancer

by Allaf, Mohamad E, Partin, Alan W, Carter, H. Ballentine
Published 2006

Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer

by Dianat, Seyed Saeid, Carter, H. Ballentine, Macura, Katarzyna J.
Published 2013

Active Surveillance for Prostate Cancer: Contemporary State of Practice

by Tosoian, Jeffrey J., Carter, H. Ballentine, Lepor, Abbey, Loeb, Stacy
Published in Nat Rev Urol (2016)

PROSPECTIVE EVALUATION OF MEN WITH STAGE T1C ADENOCARCINOMA OF THE PROSTATE

by CARTER, H. BALLENTINE, SAUVAGEOT, JURGA, WALSH, PATRICK C., EPSTEIN, JONATHAN I.
Published 1997

Active Surveillance Versus Surgery for Low Risk Prostate Cancer: A Clinical Decision Analysis

by Liu, David, Lehmann, Harold P., Frick, Kevin D., Carter, H. Ballentine
Published 2012

Active surveillance of prostate cancer: Current state of practice and utility of multiparametric magnetic resonance imaging

by Alam, Ridwan, Carter, H. Ballentine, Epstein, Jonathan I., Tosoian, Jeffrey J.
Published in Rev Urol (2017)

Prostate-Specific Antigen Velocity Risk Count Assessment: A New Concept for Detection of Life-Threatening Prostate Cancer During Window of Curability

by Carter, H. Ballentine, Kettermann, Anna, Ferrucci, Luigi, Landis, Patricia, Metter, E. Jeffrey
Published 2007

Characteristics and Experiences of Patients with Localized Prostate Cancer Who Left an Active Surveillance Program

by Berger, Zackary D., Yeh, Jonathan C., Carter, H. Ballentine, Pollack, Craig Evan
Published in Patient (2014)

Conditional Probability of Reclassification in an Active Surveillance Program for Prostate Cancer

by Alam, Ridwan, Carter, H. Ballentine, Landis, Patricia, Epstein, Jonathan I., Mamawala, Mufaddal
Published in J Urol (2015)

Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group

by Patel, Hiten D., Tosoian, Jeffrey J., Carter, H. Ballentine, Epstein, Jonathan I.
Published in JAMA Oncol (2017)

The association between clinically determined periodontal disease and prostate-specific antigen concentration in men without prostate cancer: the 2009-2010 National Health and Nutr...

by Huang, Yuhan, Michaud, Dominique S., Lu, Jiayun, Carter, H. Ballentine, Platz, Elizabeth A.
Published in Cancer Causes Control (2019)

Risk Stratification of Men Choosing Surveillance for Low Risk Prostate Cancer

by Tseng, Kenneth S., Landis, Patricia, Epstein, Jonathan I., Trock, Bruce J., Carter, H. Ballentine
Published 2010

Delayed Versus Immediate Surgical Intervention and Prostate Cancer Outcome

by Warlick, Christopher, Trock, Bruce J., Landis, Patricia, Epstein, Jonathan I., Carter, H. Ballentine
Published 2006

Is Repeat Prostate Biopsy Associated with a Greater Risk of Hospitalization? Data from SEER-Medicare

by Loeb, Stacy, Carter, H. Ballentine, Berndt, Sonja I., Ricker, Winnie, Schaeffer, Edward M.
Published 2012